This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute…

Spinal Cord Injury, Acute

~Estimated

~$10 – $6,250

University of MiamiNCT02991690

Phase 1

Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device (DOSED)

The DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a …

Spinal Cord Injury CervicalSpinal Cord Injury ThoracicSpinal Cord Injury, Acute+2 more

~Estimated

~$10 – $8,750

Lineage Cell Therapeutics, Inc.NCT06841770